[Cannabis and cannabinoids. Possibilities of their therapeutic use].
Newer aspects of therapeutic potentials of cannabis and cannabinoids are reviewed. The major active constituent of cannabis sativa, delta-9-tetrahydrocannabinol and synthetic cannabinoids are evaluated in several clinical trials on their antiemetic efficacy in cancer chemotherapy induced vomiting. 80% of patients refractory to standard antiemetic treatment could be improved with the synthetic cannabinoid levonantradol. Other therapeutic effects, which are presently investigated in clinical trials are analgesia, antispasticity, anticonvulsion and the reduction of intraocular pressure in glaucoma. The future goal of cannabinoid research is the separation between specific pharmacologic activities and undesirable psychotropic effects.
D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use; D000932:Antiemetics / Q000627:therapeutic use; D002186:Cannabinoids / Q000138:chemical synthesis / Q000627:therapeutic use*; D002188:Cannabis; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D010936:Plant Extracts
D000700:Analgesics; D000927:Anticonvulsants; D000932:Antiemetics; D002186:Cannabinoids; D010936:Plant Extracts
Cannabis und Cannabinoide Möglichkeiten ihrer therapeutischen Anwendung.